Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib
This article is from
The Cancer Letter
archive.
Vol. 37 No. 6 | June 27, 2014
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Amgen Claimed QOL Benefit Despite FDA Label Change.
May 18, 2007
TCL Archive
CMS Unable to Adjust Cuts To Cancer Care
June 7, 2013
TCL Archive
Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint
March 29, 2013
TCL Archive
ACS Awards Medals to Holland, Sporn, RWJ Foundation
December 2, 1994
TCL Archive
Abraxane and Gemcitabine Improves Overall Survival
November 30, 2012
TCL Archive
RFA Announced On Model For Planning community Prevention Program
October 20, 1978
